Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Ono Pharmaceutical Co. (OPHLF) Return on Tangible Equity data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.86B |
|
$698.13M |
|
$4.34B |
|
$7.20B |
|
$955.72M |
|
$612.00M |
|
$720.59M |
|
$1.68B |
|
$5.52B |
|
$2.92B |
|
$5.52B |
|
469.91M |
|
| Cash Flow Statement Financials | |
$371.04M |
|
$-284.36M |
|
$-241.13M |
|
$1.39B |
|
$1.24B |
|
$-153.05M |
|
-- |
|
$-127.64M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|